The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats

Journal of Applied Toxicology

Volumn 28, Issue 1, 2008, Pages 15-20

  Kaya, Hasan ^a   Koc, Ahmet ^a   Sogut, Sadik ^a   Duru, Mehmet ^a   Yilmaz, H Ramazan ^b   Uz, Efkan ^b   Durgut, Ramazan ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant; Cyclosporine A; Hepatotoxicity; N acetylcysteine; Oxidant

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN A; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SODIUM CARBONATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; LIVER TOXICITY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CYCLOSPORINE; GLUTATHIONE PEROXIDASE; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 38349057749     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1245     Document Type: Article

References (41)

1. Andrés D, Cascales M. 2002. Novel mechanism of vitamin E protection against cyclosporine A cytotoxicity in cultured rat hepatocytes. Biochem. Pharmacol. 64: 267-276.
2. Andrés D, Sanz N, Zaragoza A, Alvarez AM, Cascales M. 2000. Changes in antioxidant defense systems induced by cyclosporine A in cultures of hepatocytes from 2- and 12-month-old rats. Biochem. Pharmacol. 59: 1091-1100.
3. Actis GC, Debernardi-Venon W, Lagget M, Marzano A, Ottobrelli A, Ponzetto A, Rocca G, Boggio-Bertinet D, Balzola F, Bonin F, Verme G. 1995. Hepatotoxicity of intravenous cyclosporine A in patients with acute ulcerative colitis on total parenteral nutrition. Liver 15: 320-323.
4. Berg KJ, Forre O, Bjerkhoel F, Amundsen E, Djoseland, O, Rugstad HE, Westre B. 1986. Side effects of cyclosporine A treatment in patients with rheumatoid arthritis. Kidney Int. 29: 1180-1187.
5. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. 1984. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J. Clin. Invest. 73: 1772-1784.
6. Borel JF, Baumann G, Chapman I, Donatsch P, Fahr A, Muller EA, Vigouret JM. 1996. In vivo pharmacological effects of cyclosporin and same analogues. Adv. Pharmacol. 35: 115-246.
7. Buckpitt AR, Rollins DE, Mitchell JR. 1979. Varying effects of sulfhydryl nucleophiled on acetaminophen oxidation and sulfhydryl adduct formation. Biochem. Pharmacol. 28: 2941-2946.
8. Cadenas E, Brigelius R, Akerboom TH. 1983. Biological Oxidations, 34th Colloquim-Mosbach. Springer-Verlag, Berlin; 288.
9. Cohen SM. 2002. Current immunosuppression in liver transplantation. Am. J. Ther. 9: 119-125.
10. Cortas NK, Wakid NW. 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36: 1440-1443.
11. Durak I, Kacmaz M, Cimen MYB, Buyukkocak S, Elgun S, Ozturk HS. 2002. The effect of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues. Transplant. Immunol 10: 255-258.
12. Durak I, Ozbek H, Elgun S. 2004. Cyclosporine reduces hepatic antioxidant capacity: Protective roles of antioxidants. Int. Immuno pharmacol. 4: 469-473.
13. Duruibe VA, Okonmah A, Blyden GT. 1989. Effect of cyclosporine on rat liver and kidney glutathione content. Pharmacology 39: 205-212.
14. Esterbauer H, Cheeseman KH. 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In Oxygen Radicals in Biological Systems, Methods in Enzymology, Packer L, Glazer AN (eds). Academic Press: California; 407-421.
15. Fournier N, Ducet G, Crevat A. 1987. Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19: 297-303.
16. Fukuzawa K, Emre S, Senyuz O, Acarli K, Schwartz ME, Miller CM. 1995. N-acetyl-L-cysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 59: 6-9.
17. Galan AI, Fernandez E, Moran D, Muñnoz ME, Jimenez R. 1995. Cyclosporine A hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clin. Exp. Pharmacol. Physiol. 22: 260-265.
18. Galan AI, Munoz ME, Jimenez R. 1999. S-Adenosylmethionine protects against cyclosporine A-induced alterations in the rat liver plasma membrane fluidity and functions. J. Pharmacol. Exp. Ther. 290: 774-781.
19. Gutteridge JMC. 1995. Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin. Chem. 14: 1819-1828.
20. Hagar HH. 2004. The protective effect of taurine against cyclosporine A-induced oxidative status and hepatotoxicity in rats. Toxicol. Lett. 151: 335-343.
21. Hsu BG, Yang FL, Lee RP, Peng TC, Harn HJ, Chen HI. 2004. N-Acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. J. Biomed. Sci. 11: 152-162.
22. Inselmann G, Lawerenz HU, Nellessen U, Heidemann HT. 1994. Enhancement of cyclosporine A induced hepto- and nephro-toxicity by glutathione depletion. Eur. J. Clin. Invest. 24: 355-359.
23. Jazzar A, Fagiuoli S, Caraceni S, Deal S, Wright HI, Sisson S, Gavaler J, Van Thiel DH, Zuhdi N, Cooper DK. 1994. Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy. Transplant. Proc. 26: 2654.
24. Kahan BD. 1992. Immunosuppressive therapy. Curr. Opin. Immunol. 4: 553-560.
25. Kahan BD, Wideman CA, Reid M, Gibbons S, Jarowenko M., Flechner S, Van Buren CT. 1984. The value of serial serum trough cyclosporine levels in human renal transplantation. Transplant. Proc. 16: 1195-1199.
26. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK 506 complexes. Cell 66: 807-815.
27. Lowry O, Rosenbrough N, Farr L, Randall R. 1951. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 183: 265-275.
28. Margreiter R, Huber C, Spielberger M, Konig P. 1983. Cyclosporine in the treatment of acute cadaveric kidney graft rejection refractory to high-dose methylprednisolone. Transplantation 36: 203-204.
29. Mattila PS, Ullman KS, Fiering S, Emmel EA, McCutcheon M, Crabtree GR, Herzenberg LA. 1990. The actions of cyclosporin A and FK 506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9: 4425-4433.
30. Meister A, Anderson ME. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
31. Menashe P, Grousset C, Gaudel Y, Mouas C, Piwnica A. 1992. Maintenance of the myocardial thiol pool by N-acetylcysteine: an effective means of improving cardioplegic protection. J. Thorac. Cardiovasc. Surg. 103: 936-944.
32. Nicolli A, Basso E, Petrollini V, Wenger RM, Bernardi P. 1996. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J. Biol. Chem. 271: 2185-2192.
33. Orrenius S. 1993. Mechanisms of oxidative cell damage. In Free Radicals: From Basic Science to Medicine, Poli G, Albano E, Dianzani MU (eds). Birkhauser Verlag: Basel; 47-63.
34. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70: 158-170.
35. Rezzani R, Rodella L, Buffoli B, Goodman AA, Abraham NG, Lianos EA, Bianchi R. 2005. Change in renal heme oxygenase expression in cyclosporine A-induced injury. J. Histochem. Cytochem. 53: 105-112.
36. Ross D. 1980. Glutathione, free radicals and chemotherapeutic agents. Pharmacol. Ther. 37: 231-249.
37. Salducci MD, Chauvet-Monges AM, Berland Y, Dussol B, Elsen R, Crevat A. 1992. The restoration of ATP synthesis may explain the protective effect of calcium antagonist against cyclosporine A nephrotoxicity. Life Sci. 50: 2053-2058.
38. Schuurman HJ, van Loveren H, Rozing J, van Dijk A, Loeber JG, Vos JG. 1990. Cyclosporin and the rat thymus. An immunohistochemical study. Thymus 16: 235-254.
39. Sigal NH, Dumont FJ. 1993. Immunosuppression. In Fundamental Immunology, Paul WE (ed.). Raven Press: New York; 903-915.
40. Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34: 497-500.
41. Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P, Cordier A. 1994. Role of glutathione in cyclosporine A in vitro hepatotoxicity. J. Pharm. Exp. Ther. 280: 1328-1334.